
Morgan Stanley reported robust Q2 2025 results, with EPS of $2.13 and revenue of $16.79 billion both exceeding consensus, and net earnings climbing to $3.54 billion. However, the stock reacted negatively, which BofA attributed to elevated pre-earnings expectations, a significant $196 million jump in credit loss provisions, and investment banking performance lagging rival JPMorgan. While BofA maintains a Buy rating with a $154 target, citing attractive valuation at 15x 2026 earnings, Goldman Sachs adjusted EPS estimates and reiterated a Neutral rating with a $146 target, reflecting mixed analyst sentiment despite management's optimism for H2 2025 investment banking activity.
Morgan Stanley (MS) reported strong second-quarter 2025 results, with revenue of $16.79 billion (up 12% year-over-year) and EPS of $2.13 both surpassing consensus estimates. Despite the headline beat, the stock's initial negative reaction was attributed by Bank of America to elevated expectations following significant year-to-date gains. Key factors weighing on sentiment included a significant jump in the provision for credit losses to $196 million, driven by corporate loan growth and a moderately weaker macroeconomic outlook. Furthermore, the firm's investment banking performance was noted as lagging that of rival JPMorgan. Analyst outlook is divided: Bank of America reiterated a Buy rating with a $154 target, raising its EPS estimates and citing an attractive valuation at 15 times estimated 2026 earnings. Conversely, Goldman Sachs maintained a Neutral rating, trimming its price target to $146 based on a more conservative 14.5x P/E multiple and slightly lowering its 2026 and 2027 EPS forecasts. While management expressed optimism for a rebound in investment banking activity in the second half of 2025, this is tempered by the mixed analyst revisions and the noted increase in credit risk.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.05
Ticker Sentiment